ALPHA-MAN-[1->3][ALPHA-MAN-(1->6)]-ALPHA-MAN-[1->6][ALPHA-MAN-(1->3)]-MAN
112828-69-0
|
ALPHA-FUC-[1->2]-BETA-GAL-[1->3]-(ALPHA-FUC-[1->4])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-(ALPHA-FUC-[1->3])-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC
120864-60-0
|
beta-D-Fructofuranosyl O-beta-D-galactopyranosyl-(1-3)-alpha-D-glucopyranoside
686717-73-7
|
4-trifluoroacetamidophenyl-beta-mannopyranosyl(1-4)-alpha-rhamnopyranosyl(1-3)-alpha-galactopyranoside
85451-34-9
|
1,3-Dicyclohexyl-alpha,5-dimethyl-2,4,6-trioxohexahydro-5-pyrimidineac etic acid
129750-90-9
|
1,3-Bis(alpha-isocyanatoisopropyl)benzene
85902-02-9
|
1,3-BIS-(ALPHA,ALPHA,ALPHA,ALPHAPR,ALPHAPR,ALPHAPR-HEXAFLUORO-3,5-XYLYL)-UREA
3824-74-6
|
1,3-diacetyl-17 alpha-ethinyl-7 alpha-methyl-1,3,5(10)estratriene-17,3-ol
74178-54-4
|
1,3-Dioxolane-2-acetonitrile,-alpha--(methoxymethylene)-
87647-16-3
|
4-[(5-bromopyridin-2-yl)carbamoyl]-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid
2171708-79-3
|
3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]-2,2-dimethylpropanoic acid
2171214-28-9
|
2-[(2R)-N-cyclopropyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]acetic acid
2171237-28-6
|
RXFP2 agonist 1
2971704-58-0
|
(2S)-2-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]-3-methylbutanoic acid
116460-33-4
|
3-{N-ethyl-1-[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopropyl]formamido}butanoic acid
2171886-95-4
|
3-{2-[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]acetamido}propanoic acid
2171880-74-1
|
(2R)-2-{2-[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]acetamido}propanoic acid
2171237-32-2
|
(2S)-3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methoxybutanamido]-2-hydroxypropanoic acid
2308463-57-0
|
(2S)-2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylbutanamido]-4-hydroxybutanoic acid
2648912-34-7
|
